Pfizer | Knock Out
Pfizer is fighting for 8 cancer breakthroughs by 2030.
Related Articles
Considerations for Prescribing GLP-1s Get More Complicated
New research explores the wide world of the positives, and potential drawbacks, of new obesity medications. And each brings a new consideration for physicians.
Long-term and sequential treatment for osteoporosis
Nature Reviews Endocrinology – For patients with osteoporosis, the long-term use of bone-specific pharmacological therapies, including antiresorptive and/or osteoanabolic approaches, has raised…
Circulating Tumor DNA as Measurable Residual Disease in Aggressive B-Cell Lymphoma
This narrative review explores how the identification of measurable residual disease through methods of detecting circulating tumor DNA contributes to outcomes for B-cell lymphomas.
Lurbinectedin plus pembrolizumab in relapsed small cell lung cancer (SCLC): the phase I/II LUPER study
Small-cell lung cancer (SCLC) has limited second-line treatment options after chemotherapy. We assessed the efficacy and safety of lurbinectedin combined with pembrolizumab in relapsed SCLC…
A New Call for US Alcohol Labels to Warn of Cancer Link
This Medical News article discusses updating health warning labels on alcoholic beverages to include the fact that drinking alcohol causes certain cancers, with examples of…
Management of Locally Advanced Rectal Cancer: ASCO Guideline
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the…
Welcome! You are invited to join a webinar: IACH Journal Club-Sustained benefit of zanubrutinib vs ibrutinib in patients with R/R CLL/SLL: final comparative analysis of ALPINE. After registering, you will receive a confirmation email about joining the webinar.
The ALPINE trial established the superiority of zanubrutinib over ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma; here, we present data…
IZFS Webinars | IZFS – International Zebrafish Society
In April 2020, the International Zebrafish Society (IZFS) launched the IZFS Webinar Series. The series includes a variety of research and professional development topics. The…
EAU25 Preview: Dr. Benoit Peyronnet (FR), SCO Member, on Functional Urology
Functional Urology at EAU25: A Conversation with Dr Benoit PeyronnetIn this interview, Dr Benoit Peyronnet, one of the newest members of the EAU Scientific C…
